Insignis Therapeutics Inc.

CIK 1981826 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Insignis Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 5, 2026D0001493152-26-036132
Jun 16, 2023D0001981826-23-000001